Multimodality imaging of vulvar cancer: Staging, therapeutic response, and complications

Chitra Viswanathan, Kimberly Kirschner, Mylene Truong, Aparna Balachandran, Catherine Devine, Priya Bhosale

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

OBJECTIVE. Vulvar carcinoma is a rare malignancy, most commonly seen in elderly women. Survival depends on the lymph node status. Lymph node-negative patients have a 5-year survival of 90%, whereas survival drops to about 50% in patients with positive lymph nodes. The purpose of this article is to familiarize the reader with the revised International Federation of Gynecology and Obstetrics (FIGO) staging of vulvar cancer and incorporate it into daily practice when interpreting cross-sectional imaging studies. CONCLUSION. Although vulvar cancer is diagnosed clinically, cross-sectional imaging plays an important complimentary role in staging of the tumor, assessing extent of disease, and selecting operable versus inoperable candidates to ultimately help in decreasing morbidity and increasing survival in these patients.

Original languageEnglish
Pages (from-to)1387-1400
Number of pages14
JournalAmerican Journal of Roentgenology
Volume200
Issue number6
DOIs
StatePublished - Jun 2013

    Fingerprint

Keywords

  • Complications
  • International Federation of Gynecology and Obstetrics (FIGO)
  • MRI
  • PET/CT
  • Vulvar cancer

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

Viswanathan, C., Kirschner, K., Truong, M., Balachandran, A., Devine, C., & Bhosale, P. (2013). Multimodality imaging of vulvar cancer: Staging, therapeutic response, and complications. American Journal of Roentgenology, 200(6), 1387-1400. https://doi.org/10.2214/AJR.12.9714